335
Views
4
CrossRef citations to date
0
Altmetric
Physiology

Small airway inflammation is associated with residual airway hyperresponsiveness in Th2-high asthma

, MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, , MD, , MD, PhD, , MS, , MD, , MD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD, , MD, PhD & , MD, PhD show all
Pages 933-941 | Received 29 Nov 2018, Accepted 01 Jun 2019, Published online: 19 Jun 2019

References

  • Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2017. Available from: Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2017. Available from: http://www.ginasthma.org.
  • Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR; American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011; 184:602–615. doi: 10.1164/rccm.9120-11ST.
  • American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med. 2005;171:912–930.
  • Dweik RA, Sorkness RL, Wenzel S, Hammel J, Curran-Everett D, Comhair SA, Bleecker E, Busse W, Calhoun WJ, Castro M et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med. 2010;181:1033–1041. doi: 10.1164/rccm.200905-0695OC.
  • Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med. 2007; 176:231–237. doi: 10.1164/rccm.200610-1427OC.
  • Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005; 352:2163–2173. doi: 10.1056/NEJMoa043596.
  • Gelb AF, George SC, Silkoff PE, Krishnan A, Fraser C, Taylor CF, Shinar CM, Maginot T. Central and peripheral airway/alveolar sites of exhaled nitric oxide in acute asthma. Thorax. 2010;65:619–625. doi: 10.1136/thx.2009.132696.
  • van den Berge M, ten Hacken NH, van der Wiel E, Postma DS. Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma. Allergy. 2013;68:16–26. doi: 10.1111/all.12062.
  • Bates CA, Silkoff PE. Exhaled nitric oxide in asthma: from bench to bedside. J Allergy Clin Immunol. 2003;111:256–262.
  • Condorelli P, Shin HW, Aledia AS, Silkoff PE, George SC. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. J Appl Physiol (1985). 2007;102:417–425. doi: 10.1152/japplphysiol.00533.2006.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi: 10.1183/09031936.05.00034805.
  • Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65. doi: 10.1016/j.jaci.2003.09.008.
  • Hasegawa T, Koya T, Sakagami T, Kagamu H, Kawakami H, Hara K, Yoshimine F, Arakawa M, Gejyo F, Narita I et al. Efficacy of using the Japanese version of the asthma control test for determing the level of asthma control in clinical settings. Allergol Int. 2012;61:609–617. doi: 10.2332/allergolint.12-OA-0453.
  • Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med. 2003; 168:983–988. doi: 10.1164/rccm.200211-1268OC.
  • Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J. 1998;11:1064–1069.
  • Galera R, Casitas R, Martínez-Cerón E, Romero D, García-Río F. Does airway hyperresponsiveness monitoring lead to improved asthma control?. Clin Exp Allergy. 2015;45:1396–1405. doi: 10.1111/cea.12539.
  • Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med. 1999;159:1043–1051. doi: 10.1164/ajrccm.159.4.9806052.
  • van den Berge M, Ten Hacken NHT, Cohen J, Douma WR, Postma DS. Small airway disease in asthma and COPD: clinical implications. Chest. 2011;139:412–423. doi: 10.1378/chest.10-1210.
  • Hamid Q. Pathogenesis of small airways in asthma. Respiration. 2012;84:4–11. doi: 10.1159/000339550.
  • Zeidler MR, Goldin JG, Kleerup EC, Kim HJ, Truong DA, Gjertson DW, Kennedy NJ, Newman KB, Tashkin DP, Silverman JM et al. Small airways response to naturalistic cat allergen exposure in subjects with asthma. J Allergy Clin Immunol. 2006;118:1075–1081. doi: 10.1016/j.jaci.2006.06.042.
  • in ‘t Veen JC, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med. 2000;161:1902–1906. doi: 10.1164/ajrccm.161.6.9906075.
  • Sposato B, Scalese M, Migliorini MG, Di Tomassi M, Scala R. Small airway impairment and bronchial hyperresponsiveness in asthma onset. Allergy Asthma Immunol Res. 2014;6:242–251. doi: 10.4168/aair.2014.6.3.242.
  • Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J. 1997;10:292–300.
  • Berry M, Hargadon B, Morgan A, Shelley M, Richter J, Shaw D, Green RH, et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J. 2005;25:986–991. doi: 10.1183/09031936.05.00132404.
  • Scichilone N, Battaglia S, Taormina S, Modica V, Pozzecco E, Bellia V. Alveolar nitric oxide and asthma control in mild untreated asthma. J Allergy Clin Immunol. 2013;131:1513–1517. doi: 10.1016/j.jaci.2013.03.009.
  • Khalili B, Boggs PB, Shi R, Bahna SL. Discrepancy between clinical asthma control assessment tools and fractional exhaled nitric oxide. Ann Allergy Asthma Immunol. 2008;101:124–129. doi: 10.1016/S1081-1206(10)60199-8.
  • Mahut B, Plantier L, Malinvaud D, Chevalier-Bidaud B, Bonfils P, Delclaux C. Pathophysiology of airway hyperresponsiveness in patients with nasal polyposis. Respir Med. 2012;106:68–74. doi: 10.1016/j.rmed.2011.08.002.
  • Newman S, Salmon A, Nave R, Drollmann A. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma. Respir Med. 2006;100:375–384. doi: 10.1016/j.rmed.2005.09.027.
  • Cohen J, Douma WR, ten Hacken NH, Vonk JM, Oudkerk M, Postma DS. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J. 2008;31:1213–1220. doi: 10.1183/09031936.00082407.
  • Nakaji H, Petrova G, Matsumoto H, Iwata T, Ito I, Oguma T, Inoue H, et al. Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma. Ann Allergy Asthma Immunol. 2013;110:198–203. e193. doi: 10.1016/j.anai.2012.12.016.
  • Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J. 2001;18:635–639. doi: 10.1183/09031936.01.00000201.
  • Högman M, Lafih J, Meriläinen P, Bröms K, Malinovschi A, Janson C. Extended NO analysis in a healthy subgroup of a random sample from a Swedish population. Clin Physiol Funct Imaging. 2009;29:18–23. doi: 10.1111/j.1475-097X.2008.00831.x.
  • Gelb AF, George SC, Camacho F, Fraser C, Flynn Taylor C, Shakkottai S. Increased nitric oxide concentrations in the small airway of older normal subjects. Chest. 2011;139:368–375. doi: 10.1378/chest.10-1157.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.